Skip to main content
Veterinary Medicines

Milbemycin oxime Praziquantel Chew Alfamed II 2.5 mg / 25.0 mg chewable tablets for small dogs and puppies

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
Milbemycin oxime Praziquantel Chew Alfamed II 2.5 mg / 25.0 mg chewable tablets for small dogs and puppies
MILBEMYCIN OXIME PRAZIQUANTEL CHEW ALFAMED II 2,5 MG / 25,0 MG COMPRIMES A CROQUER POUR PETITS CHIENS ET CHIOTS
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog (puppy)
  • Dog (small)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    25.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog (puppy)
    • Dog (small)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • 1 box with 1 blister, each blister contains 2 chewable tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1974079 3/2024
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0414/001
Concerned member states:
  • France

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/08/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 14/05/2025
Updated on: 13/05/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."